Investment Rating - The report assigns a "Buy" rating for IFBH, marking its first coverage of the company [1]. Core Insights - IFBH is a leader in the coconut water sector, demonstrating strong profitability and a commitment to a light-asset model that leverages Thai industry resources [8][14]. - The coconut water market in China is rapidly expanding, with a projected growth from USD 1.02 billion in 2019 to USD 10.93 billion by 2024, reflecting a CAGR of 60.8% [8][70]. - The company is actively enhancing its distribution partnerships and product offerings to drive growth, with a focus on both online and offline channels [8][51]. Summary by Sections 1. Company Overview - IFBH was founded in 2013 and has rapidly grown since entering the Chinese market in 2017, becoming a leading player in the coconut water industry [8][14]. - The company operates under a light-asset model, which allows it to maintain high asset turnover and profitability [8][42]. 2. Market Dynamics - The coconut water industry is characterized by its health benefits and growing consumer demand, with significant room for market penetration compared to the U.S. [8][51]. - The market is expected to continue expanding, with a forecasted CAGR of 19.4% from 2024 to 2029 [70]. 3. Growth Strategy - IFBH is focusing on product innovation and expanding its distribution network, including partnerships with major retailers like COFCO and Watsons [8][51]. - The company plans to enhance its market presence through both its flagship brand "if" and the new "Innococo" brand, targeting functional beverage segments [8][29]. 4. Financial Projections - Revenue projections for IFBH indicate growth from USD 187.55 million in 2025 to USD 331.16 million by 2027, with corresponding net profits expected to rise from USD 30.50 million to USD 54.79 million [1]. - The report anticipates a decrease in P/E ratios from 19.29x in 2025 to 10.74x in 2027, indicating improving valuation metrics [1].

证券研究报告 | 公司点评 gszqdatemark 2026 01 19 年 月 日 朝云集团（06601.HK） 拟收购河北康达有望增厚业绩，加强布局北方家居护理市场 公司拟收购河北康达，加码北方家居护理市场。公司公告称拟以最高 4.5 亿元收购河北康达 100%股权，进一步提升集团在家居护理品类在 北方区域的市场竞争力，提升对国内终端市场的覆盖。收购完成后，集 团将在多方位、多角度进行资源整合，加强现有家居护理业务与河北 康达的业务之间的协同效应。 收购完成后有望增厚营收利润，可在品牌协同与品类份额等方面实现 多维协同效应。 投资建议。公司作为家居护理细分龙头，持续推进多品牌多品类全渠 道战略，加强宠物业务布局，渠道布局兼具线上高增平台及线下下沉 拓展。公司业绩稳健、现金流强劲，稳步推进产业链收并购整合。考虑 到公司收购完成后有望增厚业绩，我们预计公司 2025-2027 年营收分 别为 19.96/23.97/26.11 亿元，同比增长 9.7%/20.1%/9.0%，归母净 利润分别为 2.23/2.68/2.94 亿元，同比增长 9.8%/20.2%/9.4%，当前 市值对应 2026 年 PE ...

Investment Rating - The report assigns a "Buy" rating for IFBH, marking its first coverage [1]. Core Insights - IFBH is a leader in the coconut water sector, demonstrating strong profitability and a commitment to a light-asset model that leverages Thai industry resources [8][14]. - The coconut water market in China is rapidly expanding, with a projected growth from USD 1.02 billion in 2019 to USD 10.93 billion by 2024, reflecting a CAGR of 60.8% [8][70]. - The company is actively enhancing its distribution partnerships and product offerings to drive growth, focusing on both innovation and channel expansion [8][51]. Summary by Sections 1. IFBH: Leader in Coconut Water with Strong Profitability - IFBH was founded in 2013 and has rapidly grown in the Chinese market since entering in 2017, supported by a concentrated ownership structure and an efficient management team [8][14]. - The company has adopted a light-asset model, which allows it to maintain high asset turnover and return on equity (ROE) levels [8][42]. - The dual-brand strategy, with flagship brand "if" and sub-brand "Innococo," has contributed to a diversified product matrix, primarily focusing on coconut water [26][29]. 2. Coconut Water: Continuous Expansion and Uncertain Market Structure - The coconut water category is characterized by its natural health benefits and is experiencing significant growth, with the market expected to reach USD 26.52 billion by 2029 [8][70]. - The penetration rate of coconut water in China is still low compared to the U.S., indicating substantial room for growth [8][51]. - The competitive landscape remains fluid, with opportunities for leading brands to educate the market and enhance product innovation [8][51]. 3. Strengthening Distribution Partnerships and Product Development - IFBH is focusing on expanding its distribution network, having signed partnerships with major players like COFCO and Watsons to enhance offline presence [8][51]. - The company is also innovating its product line, including the introduction of electrolyte water under the Innococo brand, to capture growth in the sports drink segment [8][51]. - The light-asset model allows IFBH to mitigate risks associated with raw material price fluctuations while maintaining operational efficiency [8][26]. 4. Profit Forecast and Investment Rating - The report forecasts IFBH's revenue to reach USD 1.88 billion in 2025, USD 2.57 billion in 2026, and USD 3.31 billion in 2027, with corresponding growth rates of 19.0%, 36.9%, and 29.0% [8][1]. - The projected net profit for the same years is USD 0.31 billion, USD 0.42 billion, and USD 0.55 billion, with growth rates of -8.4%, 39.1%, and 29.1% respectively [8][1].

证券研究报告 | 公司点评 gszqdatemark 2026 01 19 年 月 日 朝云集团（06601.HK） 拟收购河北康达有望增厚业绩，加强布局北方家居护理市场 公司拟收购河北康达，加码北方家居护理市场。公司公告称拟以最高 4.5 亿元收购河北康达 100%股权，进一步提升集团在家居护理品类在 北方区域的市场竞争力，提升对国内终端市场的覆盖。收购完成后，集 团将在多方位、多角度进行资源整合，加强现有家居护理业务与河北 康达的业务之间的协同效应。 收购完成后有望增厚营收利润，可在品牌协同与品类份额等方面实现 多维协同效应。 投资建议。公司作为家居护理细分龙头，持续推进多品牌多品类全渠 道战略，加强宠物业务布局，渠道布局兼具线上高增平台及线下下沉 拓展。公司业绩稳健、现金流强劲，稳步推进产业链收并购整合。考虑 到公司收购完成后有望增厚业绩，我们预计公司 2025-2027 年营收分 别为 19.96/23.97/26.11 亿元，同比增长 9.7%/20.1%/9.0%，归母净 利润分别为 2.23/2.68/2.94 亿元，同比增长 9.8%/20.2%/9.4%，当前 市值对应 2026 年 PE ...

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [10][12]. Core Insights - The company has established a comprehensive GBC (Government, Business, Consumer) business model that integrates AI capabilities across the entire medical service cycle, from health risk warning to chronic disease management [4][20]. - The company is expected to achieve revenues of 920 million, 1.18 billion, and 1.47 billion RMB for the years 2025, 2026, and 2027, respectively, reflecting year-on-year growth rates of 25.6%, 27.6%, and 25.0% [4][10]. Summary by Relevant Sections Company Overview - Founded in 2016, the company leverages the iFlytek Spark Medical Model to provide solutions covering the entire medical service cycle [7][20]. - The ownership structure is concentrated, with iFlytek Group holding 49.4% of shares, ensuring strategic alignment and resource allocation [26][28]. Business Model and Market Position - The company has a significant first-mover advantage, having accumulated extensive data assets through early strategic positioning [8][10]. - The GBC model encompasses a complete medical service loop, addressing challenges in data flow within the healthcare industry [8][10]. Financial Performance - Revenue has shown robust growth, increasing from 373 million RMB in 2021 to an expected 734 million RMB in 2024, with a compound annual growth rate of 25.4% [36]. - The company has improved its net loss from -189 million RMB in 2022 to -133 million RMB in 2024, indicating a positive trend in financial health [37]. Growth Drivers - The company is positioned to benefit from accelerating digitalization and intelligence demands in the healthcare sector, with G and B segments providing stable revenue growth in the short term [10][20]. - The C segment, focusing on patient management services, is anticipated to be a core growth driver in the medium term [10][20]. Technological Advancements - The company has developed the Spark Medical Model, which is the only medical deep reasoning model trained on fully domestic computing power, enhancing its competitive edge [60][61]. - The integration of AI technologies into various healthcare applications is expected to significantly improve operational efficiency and patient outcomes [60][61].

交银国际研究 公司更新 消费 2026 年 1 月 16 日 李宁 (2331 HK) 收盘价 目标价 潜在涨幅 港元 19.55 港元 19.50↑ -0.3% 4 季度流水降幅收窄，复苏动能尚待稳固；维持中性评级 资料来源：公司资料，交银国际预测 此报告最后部分的分析师披露、商业关系披露和免责声明为报告的一部分，必须阅读。 下载本公司之研究报告，可从彭博信息：BOCM 或 https://research.bocomgroup.com 个股评级 中性 1 年股价表现 资料来源 : FactSet 1/25 5/25 9/25 1/26 -10% -5% 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 2331 HK 恒生指数 股份资料 | 52周高位 (港元) | 20.28 | | --- | --- | | 52周低位 (港元) | 13.96 | | 市值 (百万港元) | 50,350.24 | | 日均成交量 (百万) | 10.88 | | 年初至今变化 (%) | 4.71 | | 200天平均价 (港元) | 17.68 | | 资料来源 : FactSet | ...

Investment Rating - The investment rating for the company is "Buy" with a current price of HKD 87.20 and a fair value of HKD 121.32 [5]. Core Insights - The company is expected to benefit from both same-store sales growth and expansion, with a 2025 profit forecast slightly exceeding expectations. The projected net profit for 2025 is between RMB 4.95 billion and RMB 5.25 billion, representing a year-on-year growth of 50%-60% [7]. - The management's background in e-commerce has allowed the company to effectively capture the benefits of the takeaway market, enhancing user acquisition and retention capabilities. The main brand is expected to maintain resilience in same-store sales growth [7]. - The company has opened 905 new franchise stores and closed 645 in the first half of 2025, with a net increase of approximately 2,000 stores expected by the end of the year [7]. - The adjusted net profit forecasts for 2025, 2026, and 2027 are RMB 5.7 billion, RMB 6.6 billion, and RMB 7.7 billion, respectively, indicating a clear growth strategy [7]. Financial Summary - Revenue projections for the company are as follows: RMB 3.348 billion in 2023, RMB 3.285 billion in 2024, RMB 4.348 billion in 2025, RMB 4.917 billion in 2026, and RMB 5.719 billion in 2027, with growth rates of 52.3%, -1.9%, 32.4%, 13.1%, and 16.3% respectively [4][11]. - The EBITDA is expected to grow from RMB 610 million in 2023 to RMB 988 million in 2027, with corresponding growth rates of 52.3%, -1.9%, 32.4%, 13.1%, and 16.3% [4]. - Non-GAAP net profit is projected to increase from RMB 416 million in 2023 to RMB 775 million in 2027, with growth rates of 169.8%, 0.4%, 37.5%, 14.6%, and 17.7% [4][11]. - The company maintains a strong return on equity (ROE) of 49.6% in 2023, expected to decrease gradually to 29.8% by 2027 [4][11].

Investment Rating - The investment rating for JD Group is maintained at "Outperform the Market" [2][5][11] Core Views - The upcoming Q4 2025 financial report is expected to show revenue under pressure due to the reduction of national subsidies, with a projected revenue of CNY 348.8 billion, reflecting a year-on-year growth of only 0.5% [4][6] - The Non-GAAP net profit margin is anticipated to decline by 3 percentage points to 0.2% in Q4 2025, primarily due to the impact of subsidy reductions and an increase in the proportion of supermarket sales [4][7] - Revenue growth for JD Retail is expected to decrease by 3%, with significant declines in the sales of electronic products and home appliances, while the daily necessities category is projected to maintain double-digit growth [4][6] Revenue and Profit Forecast - Revenue forecasts for 2025-2027 have been adjusted to CNY 1,305.6 billion, CNY 1,396.9 billion, and CNY 1,494.3 billion, reflecting adjustments of -2.2%, -2.5%, and -4.1% respectively [5][11] - Adjusted net profit forecasts for the same period are CNY 26.5 billion, CNY 29.6 billion, and CNY 33.3 billion, with adjustments of -11.9%, -28.6%, and -42.0% respectively [5][11] Operational Insights - The overall GMV (Gross Merchandise Volume) for Q4 is expected to show low single-digit negative growth, influenced by the reduction of national subsidies and high base effects [4][6] - Active purchasing users and purchase frequency in e-commerce remain strong, although the decline in high-ticket items due to subsidy reductions is expected to impact average transaction prices and GMV growth [4][6]

Investment Rating - The report maintains a "Buy" rating for the company [7] Core Views - As of January 12, 2026, the company's PE ratio is 31.42x, positioned at the 24th percentile historically since 2016, indicating a certain level of investment value. It is expected that the continuous enhancement of the mutual market access policy will elevate liquidity in the Hong Kong capital market, leading to increased market activity and valuation. The company is projected to achieve revenues and other income of HKD 30.1 billion, HKD 32.7 billion, and HKD 35.1 billion for 2025, 2026, and 2027 respectively, with net profits attributable to shareholders of HKD 17.4 billion, HKD 19.2 billion, and HKD 20.8 billion, corresponding to PE valuations of 31.5x, 28.6x, and 26.3x respectively [2][50] Summary by Relevant Sections Market Environment - The Hong Kong stock market continued its upward trend in December, supported by domestic policy drivers and expectations of interest rate cuts from the Federal Reserve. The Hang Seng Index and Hang Seng Tech Index increased by 27.8% and 23.5% respectively compared to the end of 2024. The total market capitalization of listed securities on the Hong Kong Stock Exchange reached HKD 47.39 trillion, with a year-on-year increase of 34.2% [10][15] Trading Volume - The average daily trading (ADT) for the Hong Kong stock market in December was HKD 186 billion, reflecting a month-on-month decrease of 19.4% but a year-on-year increase of 31.0%. Northbound trading ADT was HKD 229.7 billion, down 5.5% month-on-month but up 11.6% year-on-year. Southbound trading ADT was HKD 83.6 billion, down 14.6% month-on-month but up 26.5% year-on-year [15][19] Derivatives Market - In December, the trading volume of futures and options decreased month-on-month. The average daily volume (ADV) for futures was 517,000 contracts, down 18.8% month-on-month and 12.6% year-on-year. The ADV for options was 823,000 contracts, down 18.9% month-on-month but up 13.5% year-on-year [19] Primary Market - The IPO scale in the Hong Kong market saw a significant year-on-year increase in December, with 26 new stocks listed, raising a total of HKD 25.7 billion, which is a 189% increase year-on-year but a 39% decrease month-on-month. The total number of new listings for 2025 was 117, with a cumulative scale of HKD 286 billion, representing a 224% year-on-year increase [29][30] Investment Income - As of the end of December, the relevant interest rates for investment income showed a general decline. The 6-month HIBOR was 2.99%, down 0.23 percentage points month-on-month and down 1.21 percentage points year-on-year [39] Macroeconomic Environment - The domestic economic outlook improved, with the manufacturing PMI for December at 50.10, indicating growth. The overseas liquidity is expected to enhance further due to a cooling job market and anticipated interest rate cuts by the Federal Reserve [43][45]

Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company is leveraging Generative Engine Optimization (GEO) technology to enhance visibility and accuracy in AI-generated search results, with a significant shift in marketing budgets expected towards GEO by 2025 [2][3] - The company has developed a structured corpus of product information that can dynamically update based on social media trends, allowing for rapid content iteration [3] - The AI system supports 28 languages, enabling localized marketing strategies that adapt to cultural nuances and consumer preferences in various regions [4] Financial Projections - Revenue is projected to grow from 76.38 billion CNY in 2025 to 122.78 billion CNY in 2027, with year-on-year growth rates of 38%, 28%, and 25% respectively [5] - Net profit is expected to increase from 2.69 billion CNY in 2025 to 5.15 billion CNY in 2027, with a compound annual growth rate of 38.3% [5] - Earnings per share (EPS) are forecasted to rise from 0.60 CNY in 2025 to 1.14 CNY in 2027, with corresponding price-to-earnings (PE) ratios of 22.2X, 14.9X, and 11.6X [5][8]